BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations (Q85236158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

William Vermi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Fabio Facchetti

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

Silvia Lonardi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

Piera Balzarini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

Marta Cigognetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

3

Simona Fisogni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

Vilma Pellegrini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Andrea Tironi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Luisa Bercich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Mattia Bugatti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Giulio Rossi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Bruno Murer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Mattia Barbareschi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Silvia Giuliani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Gianpietro Marchetti

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

29 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1043-1057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26022455%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2015.65

15 February 2020

exact match

0 references

cites work

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

1 reference

12 December 2020

p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens

1 reference

12 December 2020

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

1 reference

12 December 2020

Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study

1 reference

12 December 2020

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms

1 reference

12 December 2020

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

1 reference

12 December 2020

How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study.

1 reference

12 December 2020

The European mesothelioma epidemic

1 reference

12 December 2020

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

1 reference

12 December 2020

The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations

1 reference

12 December 2020

p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma

1 reference

12 December 2020

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.

1 reference

12 December 2020

Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells

1 reference

12 December 2020

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity

1 reference

12 December 2020

The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression

1 reference

12 December 2020

Frequent mutation of BAP1 in metastasizing uveal melanomas

1 reference

12 December 2020

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

1 reference

12 December 2020

Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers

1 reference

12 December 2020

Importance of gender in diffuse malignant peritoneal mesothelioma.

1 reference

12 December 2020

Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition

1 reference

12 December 2020

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

1 reference

12 December 2020

p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections

1 reference

12 December 2020

Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium

1 reference

12 December 2020

Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis

1 reference

12 December 2020

High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma

1 reference

12 December 2020

Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry

1 reference

12 December 2020

Germline mutations in BAP1 impair its function in DNA double-strand break repair

1 reference

12 December 2020

Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma

1 reference

12 December 2020

Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium

1 reference

12 December 2020

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.

1 reference

12 December 2020

Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation

1 reference

12 December 2020

Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update

1 reference

12 December 2020

Germline mutations in BAP1 predispose to melanocytic tumors

1 reference

12 December 2020

The separation of benign and malignant mesothelial proliferations

1 reference

12 December 2020

Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions

1 reference

12 December 2020

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma

1 reference

12 December 2020

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

1 reference

12 December 2020

1 reference

12 December 2020

Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies

1 reference

12 December 2020

The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant.

1 reference

12 December 2020

The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis

1 reference

12 December 2020

The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions

1 reference

12 December 2020

Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases

1 reference

12 December 2020

IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology

1 reference

12 December 2020

Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations

1 reference

12 December 2020

Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions

1 reference

12 December 2020

Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells

1 reference

12 December 2020

Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data

1 reference

12 December 2020

Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

1 reference

12 December 2020

Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register

1 reference

12 December 2020

p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology

1 reference

12 December 2020

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

1 reference

12 December 2020

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

1 reference

12 December 2020

A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression

1 reference

12 December 2020

Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling

1 reference

12 December 2020

Mesothelioma epidemiology, carcinogenesis, and pathogenesis

1 reference

12 December 2020

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.

1 reference

12 December 2020

A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.

1 reference

12 December 2020

Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma

1 reference

12 December 2020

CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma

1 reference

12 December 2020

Sarcomatoid neoplasms of the lung and pleura

1 reference

12 December 2020

Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models.

1 reference

12 December 2020

9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis

1 reference

12 December 2020

Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair

1 reference

12 December 2020

Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage

1 reference

12 December 2020

Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids

1 reference

12 December 2020

The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.

1 reference

12 December 2020

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma

1 reference

12 December 2020

IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations.

1 reference

12 December 2020

BAP1 protein is a progression factor in malignant pleural mesothelioma

1 reference

12 December 2020

Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.

1 reference

12 December 2020